Studies on the muscarinic and antimuscarinic acitivity of benzyltrimethylammonium bromide (BTM).
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007583:Jejunum / Q000187:drug effects; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D010277:Parasympathomimetics / Q000494:pharmacology*; D011189:Potassium Chloride / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D013997:Time Factors
D006584:Hexamethonium Compounds; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; D011189:Potassium Chloride; D009020:Morphine; D001285:Atropine; D006632:Histamine; D000109:Acetylcholine; D004837:Epinephrine